Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002108100 | SCV002393893 | likely benign | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2024-03-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222756 | SCV002500349 | uncertain significance | not specified | 2022-03-13 | criteria provided, single submitter | clinical testing | Variant summary: SMPD1 c.1253G>A (p.Arg418Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 248074 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in SMPD1 causing Niemann-Pick Disease (6e-05 vs 0.0022), allowing no conclusion about variant significance. c.1253G>A has been reported in the literature as a non-informative genotype (second allele not reported/specified) among cohorts of patients with Parkinson Disease (example, Robak_2017, Alcalay_2019). These report(s) do not provide unequivocal conclusions about association of the variant with Niemann-Pick Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Revvity Omics, |
RCV003138079 | SCV003822015 | uncertain significance | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing |